Noninvasive testing for NAFLD crucial for people with diabetes

Noninvasive testing for NAFLD crucial for people with diabetes

Providers should closely monitor people with diabetes and other high-risk adults for nonalcoholic fatty liver disease and consider multiple noninvasive tests to detect the presence of advanced fibrosis, according to a speaker.Mazen Noureddin, MD, MHSc, director of the fatty liver program at Cedars-Sinai, said about 73% of people with diabetes also have nonalcoholic fatty liver disease (NAFLD), making it crucial for providers to conduct screening to monitor the development of advanced disease.“We think this disease should be identified early in the high-risk population using noninvasiveRead More

Share on facebook
Share on twitter
Share on linkedin